Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ESC 24: EPIC-CAD: Edoxaban vs Dual Antiplatelet Therapy in AF & CAD
Author(s): Gi-Byoung Nam , Min Soo Cho Added: 1 year ago
ESC Congress 2024 — Edoxaban monotherapy significantly improves outcomes in high-risk patients with CAD and atrial fibrillation.Investigators, Dr Gi-Byoung Nam (Ulsan University Hospital, Ulsan, SK) and Dr Min Soo Cho (Asan Medical Center, Seoul, SK) join us to discuss the key findings from the EPIC-CAD trial (NCT03718559).This Korean multi-centre, open-labelled, randomised controlled study… View more

Anticoagulation

Electrophysiology & Arrhythmia
Rivaroxaban Monotherapy Shows Consistent Benefit Across Age Groups in AF and Stable CAD
Added: 2 months ago Source:  Arrhythmia Academy
Managing antithrombotic therapy in older patients with both atrial fibrillation (AF) and stable coronary artery disease (CAD) presents a clinical challenge, balancing the risks of thrombotic events and bleeding. A new post hoc analysis of the AFIRE trial sought to clarify whether the effects of rivaroxaban monotherapy differ across age groups compared to combination therapy with an antiplatelet… View more

Anticoagulation

Demographic
Job title: Martin Bucksbaum Distinguished University Chair, Professor and Director
Overview of Genetic Risk Factors and Aetiologies
Author(s): Sarah Ming Li Tan , Shir Lynn Lim , Marcus EH Ong , et al Added: 2 months ago

Electrophysiology & Arrhythmia

Heart Failure
Chao Gao
Chao Gao

Author

Research Area(s) / Expertise:

Intervention

 Job title: Interventional Cardiologist
Dr Chao Gao is an Interventional Cardiologist at XiJing Hospital in Xi’an, China, where he has worked since 2009. He studied medicine at The Fourth Military Medical University, earning both his Bachelor of Medicine and Master’s degree in Cardiology, and his research focuses on translational basic research and clinical trials relating to coronary artery disease and structural heart disease. View more
Job title: Professor of Medicine
Dr. William E. Boden is Professor of Medicine at Boston University School of Medicine and Lecturer in Medicine, Harvard Medical School, in Boston, Massachusetts. In July 2016, Dr. Boden returned to the VA Boston Healthcare System to assume new duties as the Physician Research Lead for the New England VA Healthcare System and as the Scientific Director of the Clinical Trials Network, which is… View more
Imag
Job title: Professor Nicolau’s main area of research includes the broad spectrum of coronary artery disease (mainly ACS)
Prof José C Nicolau, Director of the Clinical Unit of Acute Coronary Disease of the Heart Institute - InCor / HCFMUSP, University of São Paolo, Brazil Professor Nicolau’s main area of research includes the broad spectrum of coronary artery disease (mainly ACS), including hyperglycemia, LV remodeling, platelet reactivity, and antithrombotic therapy. He has participated in more than 80… View more
ESC Take-homes: Revolutionising Thrombosis Treatment in ACS, SSP and AF
Author(s): Carolyn Lam , Jeffrey Weitz Added: 2 months ago
Hear from Prof Carolyn Lam and Prof Jeffrey Weitz as they share key take-home messages from ESC 2025.Filmed onsite, this peer-to-peer discussion distils the latest updates in thrombosis management for acute coronary syndrome (ACS), secondary stroke prevention (SSP) and atrial fibrillation (AF).Register for the upcoming Q&A webinar, taking place on 6 October (14:00 EDT / 20:00 CEST), to put your… View more

Anticoagulation

Electrophysiology & Arrhythmia
Daniel JFM Thuijs
Research Area(s) / Expertise:
Dr Daniel Thuijs, MD, currently works as a PhD-fellow at the Department of Cardiothoracic Surgery, Erasmus MC. He will start his Residency in Cardiothoracic surgery in October '19. Daniel is involved in research regarding Cardiothoracic surgery and Cardiology. Currently, his main projects are, among others, (i) the "SYNTAX Extended Survival study" (10-year survival follow-up on patients (n=1800)… View more